Facebook Pixel Code

Panacea Biotec Share Price

NSE
BSE

PANACEA BIOTEC

Sector : Pharmaceuticals and health care | Smallcap | BSE

Here's the live share price of Panacea Biotec along with daily highs, lows, percentage changes and volume trends, and, all financial information.

₹446.75
-2.94₹ -13.55
As on Sep 18, 2025, 2:26 PM IST
Intraday
1W
1M
3M
6M
YTD
1Y
3Y
5Y
10Y

Panacea Biotec Price Performance

Today's LowToday's High
₹446.70₹467.90
₹446.75
52 Weeks' Low52 Weeks' High
₹259.40₹581.00
₹446.75
Open Price
₹467.90
Prev. Close
₹460.30
Volume
13,013

Over the last 5 years, the share price of Panacea Biotec has gained 16.73% CAGR. Over the past year, the corresponding return has been 29.10%.

Panacea Biotec’s current P/E of 238.34x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Highest YOY Quarterly profit growth Screener.

Panacea Biotec Peer Comparision

Stock Performance
Ratio Performance
Name
1W(%)
1M(%)
3M(%)
6M(%)
1Y(%)
3Y(%)
5Y(%)
Panacea Biotec
4.029.474.388.5428.5447.4016.63
Sun Pharmaceutical Industries
2.060.64-0.29-6.05-10.3623.3925.71
Divi's Laboratories
1.05-1.46-7.065.1711.1218.8512.67
Cipla
0.770.554.984.26-4.7814.9814.28
Torrent Pharmaceuticals
-0.37-2.3610.5413.756.1534.0919.94
Dr. Reddy's Laboratories
1.194.360.4713.240.4017.184.36
Mankind Pharma
0.325.4710.6521.368.6922.3012.84
Zydus Lifesciences
-0.275.498.6615.24-3.5842.4920.53
Lupin
2.763.764.600.40-8.1347.1313.49
Abbott India
0.05-5.02-1.644.0011.4921.2513.42
Alkem Laboratories
1.442.3613.9513.72-10.1219.0413.89
Aurobindo Pharma
0.492.300.72-1.94-27.5428.976.12
Glenmark Pharmaceuticals
-1.556.0626.1443.6427.2978.1132.71
Laurus Labs
2.115.5937.7455.7288.4421.6625.06
Biocon
0.300.216.668.570.367.96-4.26
Anthem Biosciences
3.866.4016.6616.6616.665.273.13
GlaxoSmithKline Pharmaceuticals
-4.19-1.64-16.46-1.72-1.8424.8110.06
Cohance Lifesciences
-8.251.56-9.31-19.42-20.2625.6818.71
Ipca Laboratories
1.13-4.16-2.60-1.43-8.1215.674.08
Gland Pharma
1.731.4115.3426.458.53-3.791.89

Over the last one year, Panacea Biotec has gained 28.54% compared to peers like Sun Pharmaceutical Industries (-10.36%), Divi's Laboratories (11.12%), Cipla (-4.78%). From a 5 year perspective, Panacea Biotec has outperformed peers relative to Sun Pharmaceutical Industries (25.71%) and Divi's Laboratories (12.67%).

Panacea Biotec Financials

Consolidated
Standalone
Quarterly P&L
Annual P&L
Balance Sheet
Cash Flow
Income Statement
Ratios

Panacea Biotec Stock Technicals

Moving Average

DaySMAEMA
5425.99427.7
10418.05422.75
20412.63418.43
50415.71421.32
100450.59426.48
200431.62405.22

Panacea Biotec Share Holding Pattern

In the latest quarter, Panacea Biotec remained same as its previous close in promoter holding, while DII stake increased to 1.52%, FII holding fell to 0.79%, and public shareholding moved up to 25.20% compared to the previous quarter — reflecting a shift in investor sentiment across categories.

Panacea Biotec Corporate Actions

Date Time
Announcement
Sep 08, 2025, 11:27 PM ISTPanacea Biotec L - Demat Status Report For The Month Of August 2025
Sep 08, 2025, 10:08 PM ISTPanacea Biotec L - Business Responsibility and Sustainability Reporting (BRSR)
Sep 08, 2025, 10:04 PM ISTPanacea Biotec L - Reg. 34 (1) Annual Report.
Sep 08, 2025, 9:51 PM ISTPanacea Biotec L - Intimation Of 41St Annual General Meeting Of The Company To Be Held On Tuesday, September 30, 2025 At 11:3
Aug 14, 2025, 11:55 PM ISTPanacea Biotec L - Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For

About Panacea Biotec

Panacea Biotec Ltd. is a Public Limited Listed company incorporated on 02/02/1984 and has its registered office in the State of Punjab, India. Company's Corporate Identification Number(CIN) is L33117PB1984PLC022350 and registration number is 022350. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 309.85 Cr. and Equity Capital is Rs. 6.13 Cr. for the Year ended 31/03/2025.

Management

  • Dr. Rajesh Jain
    Chairman & Managing Director
  • Mr. Sandeep Jain
    Joint Managing Director
  • Mr. Ankesh Jain
    Whole Time Director
  • Mrs. Ambika Sharma
    Non Executive Director
  • Mr. N N Khamitkar
    Non Executive Director
  • Mr. Mukul Gupta
    Non Executive Director
  • Mr. Narotam Kumar Juneja
    Non Executive Director
  • Mr. K M Lal
    Non Executive Director
  • Mrs. Manjula Upadhyay
    Non Executive Director
  • Mr. Bhupinder Singh
    Non Executive Director

FAQs on Panacea Biotec Share Price

What is the share price of Panacea Biotec?

The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Panacea Biotec is ₹446.75 as on Sep 18, 2025.

What kind of stock is Panacea Biotec?

The Panacea Biotec is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.

What is the Market Cap of Panacea Biotec?

The market cap of Panacea Biotec is ₹2,736.07 Cr as on Sep 18, 2025.

What are today's High and Low prices of Panacea Biotec?

Today’s highest and lowest price of Panacea Biotec are ₹467.90 and ₹446.70.

What are the 52 Week High and 52 Week Low of Panacea Biotec?

The 52-week high/low is the highest and lowest price at which Panacea Biotec stock has traded in the past 52-week or nearly a year. The 52-week high of Panacea Biotec is ₹581.00 and 52-week low of Panacea Biotec is ₹259.40 as on Sep 18, 2025.

How has the Panacea Biotec performed historically in terms of returns?

The Panacea Biotec has shown returns of -2.52% over the past day, 9.95% for the past month, 4.84% over 3 months, 29.1% over 1 year, 47.61% across 3 years, and 16.73% over 5 years.

What are the P/E ratio, dividend yield and PB ratio of Panacea Biotec?

P/E ratio of and PB ratio of Panacea Biotec are 238.34 and 3.28 on Sep 18, 2025. While the company gives a dividend yield of 0.00 per annum.

icon
Market Data